GRAMEGNA, ANDREA
GRAMEGNA, ANDREA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Standards of care and educational gaps in adult cystic fibrosis units: a European Respiratory Society survey
2024 A. Felipe Montiel, A. Álvarez Fernández, M. Culebras Amigo, F. Blasi, A. Gramegna, S. Elborn, A. Horsley, S. Madge, D. Stolz, N. Tabin, C. Pannetier, E. Polverino
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders
2024 F. Amati, G. Leonardi, M. Contarini, L.C. Morlacchi, A. Stainer, G. Pizzamiglio, S. Aliberti, F. Blasi, A. Gramegna
Standards for the care of people with cystic fibrosis (CF); Planning for a longer life
2024 A. Gramegna, C. Addy, L. Allen, E. Bakkeheim, C. Brown, T. Daniels, G. Davies, J.C. Davies, K. De Marie, D. Downey, I. Felton, S. Hafkemeyer, S. Hamouda, V. Kendall, U. Lindberg, M. Macek, S. Mayell, O. Pearlsman, M.S. Schechter, L. Salvatori, D. Sands, C. Schwarz, M. Shteinberg, J. Taylor, J.L. Taylor-Cousar, D. Taylor-Robinson, B. Watkins, M. Verkleij, A. Bevan, C. Castellani, P. Drevinek, S. Gartner, E. Lammertyn, E.(.C. Landau, P.G. Middleton, B.J. Plant, A.R. Smyth, S. van Koningsbruggen-Rietschel, P. Burgel, K.W. Southern
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
2024 A. Lombardi, S. Villa, M. Colaneri, G. Scaglione, F. Bai, B. Varisco, V. Bono, A. Vena, C. Dentone, C. Russo, M. Tettamanti, G. Renisi, G. Viero, C. Azzarà, M. Mantero, F. Peyvandi, M. Bassetti, G. Marchetti, A. Muscatello, A. Nobili, A. Gori, A. Bandera, S. Bosari, L. Scudeller, G. Fusetti, L. Rusconi, S. Dell’Orto, D. Prati, L. Valenti, S. Giovannelli, M. Manunta, G. Lamorte, F. Ferarri, D. Mangioni, L. Alagna, G. Bozzi, A. Lombardi., R. Ungaro, G. Ancona, M. Mussa, B.V. Mariani, M. Bolis, N. Iannotti, S. Ludovisi, A. Comelli, S. Biscarini, V. Castelli, E. Palomba, M. Fava, C.A. Peri, P. Saltini, T. Itri, V. Ferroni, V. Pastore, R. Massafra, A. Liparoti, T. Muheberimana, A. Giommi, R. Bianco, G.E. Chitani, C. Bobbio, I. De Matteis, A.B. Bonomi, R. Gualtierotti, B. Ferrari, R. Rossio, N. Boasi, E. Pagliaro, C. Massimo, M. De Caro, A. Giachi, N. Montano, B. Vigone, C. Bellocchi, A. Carandina, E. Fiorelli, V. Melli, E. Tobaldini, F. Blasi, S. Aliberti, M. Spotti, L. Terranova, S. Misuraca, A. D’Adda, S. Della Fiore, M. Di Pasquale, M. Contarini, M. Ori, L. Morlacchi, V. Rossetti, A. Gramegna, M. Pappalettera, M. Cavallini, A. Buscemi, M. Vicenzi, I. Rota, G. Costantino, M. Solbiati, L. Furlan, M. Mancarella, G. Colombo, G. Colombo, A. Fanin, M. Passarella, V. Monzani, C. Canetta, A. Rovellini, L. Barbetta, F. Billi, C. Folli, S. Accordino, D. Maira, C.M. Hu, I. Motta, N. Scaramellini, A.L. Fracanzani, R. Lombardi, A. Cespiati, M. Cesari, T. Lucchi, M. Proietti, L. Calcaterra, C. Mandelli, C. Coppola, A. Cerizza, A.M. Pesenti, G. Grasselli, A. Galazzi, I. Monti, A.A. Galbussera, E. Crisafulli, D. Girelli, A. Maroccia, D. Gabbiani, F. Busti, A. Vianello, M. Biondan, F. Sartori, P. Faverio, A. Pesci, S. Zucchetti, P. Bonfanti, M. Rossi, I. Beretta, A. Spolti, S. Harari, D. Elia, R. Cassandro, A. Caminati, F. Cipollone, M.T. Guagnano, D. D’Ardes, I. Rossi, F. Vezzani, A. Spanevello, F. Cherubino, D. Visca, M. Contoli, A. Papi, L. Morandi, N. Battistini, G.L. Moreo, P. Iannuzzi, D. Fumagalla, S. Leone
Lung Clearance Index Improves in People with Cystic Fibrosis not Achieving a Clinical Important Difference in Forced Expiratory Volume in One Second After Elexacaftor/Tezacaftor/Ivacaftor Therapy
2024 V. Daccò, A. Gramegna, C. Rosazza, A. Mariani, A. Biffi, C. Lanfranchi, L. Zazzeron, F. Bellante, F. Blasi, G. Alicandro
Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis
2024 A. Gramegna, S. Aliberti, A. Amorim, F. Blasi, S. Bourke, P. Burgel, F. Diamantea, I. Durieu, L. Fila, R.M.G. Moreno, B. Messore, E. Pokojová, G. Taccetti, S. Verhulst, A.V. Dugac, S. Wege, A. Duff, K.W. Southern, C. Castellani
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease
2024 A. Gramegna, G. Alicandro, C. Premuda, F. Lucca, L. Pinali, M. Retucci, V. Vespro, M.C. Andrisani, G. Carraffiello, F. Amati, S. Volpi, S. Aliberti, M. Cipolli, F. Blasi
The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis
2024 A. Gramegna, I. Barone, G. Alicandro, G. Sotgiu, A. Bellofiore, C. Colombo, A. Arcadu, M. Ori, F. Blasi, E. Simonetta, M. Vicenzi, S. Aliberti, F. Blasi
Single-Cell RNA Sequencing Shows that Circulating Monocytes Enriched in IFN Signaling Are Associated with Nontuberculous Mycobacteria Pulmonary Disease in Cystic Fibrosis
2024 N.I. Lorè, A. Gramegna, S. de Pretis, F. Di Marco, F. Giannese, F. Saliu, C. Oneto, M. Contarini, L. Cariani, F. Blasi, D.M. Cirillo
Bronchiectasis in a patient with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: a case report
2024 M.S. Silani, E. Simonetta, A. Gramegna, A. De Angelis, F. Blasi, S. Aliberti
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review
2024 G. Bongiovanni, A. Tonutti, A. Stainer, M. Nigro, D.L. Kellogg, A. Nambiar, A. Gramegna, M. Mantero, A. Voza, F. Blasi, S. Aliberti, F. Amati
Perceived burden of respiratory physiotherapy in people with cystic fibrosis taking elexacaftor–tezacaftor–ivacaftor combination: a 1-year observational study
2024 C. Blardone, S. Gambazza, A. Mariani, R. Galgani, A. Brivio, R.M. Nobili, C. Rizza, A.L. Tutino, A. Gramegna, V. Daccò, M. Contarini, F. Blasi, D. Laquintana
Diagnostic delay in bronchiectasis: an Italian perspective
2024 C. Chessari, E. Simonetta, F. Amati, M. Nigro, A. Stainer, G. Sotgiu, M. Puci, A. Gramegna, F. Blasi, L.C. Morlacchi, A.A.M.D. Buscemi, V. Conio, V. Sanci, A.G. Corsico, P. Faverio, W. Michalak, F. Luppi, C. Crimi, C. Vancheri, R. Campisi, M.R. Vulpi, G.E. Carpagnano, M. Cicchetti, K. Sekretna, N. Scichilone, S. Battaglia, S. Aliberti
Comments on PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV
2023 A. Lombardi, A. Gramegna, P. Gruarin, R. Grifantini, A. Gori, F. Blasi, A. Bandera
Idiopathic interstitial pneumonia in a patient with von Hippel-Lindau syndrome: a first case
2023 L.C. Morlacchi, U. Zanini, A. Gramegna, P. Faverio, F. Blasi, F. Luppi
Treatable traits in interstitial lung diseases: a call to action
2023 F. Amati, P. Spagnolo, J.M. Oldham, C.J. Ryerson, A. Stainer, A. Gramegna, M. Mantero, D. Lacedonia, N. Sverzellati, L. Richeldi, F. Blasi, S. Aliberti
The impact of elexacaftor/tezacaftor/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: An expert-based Delphi consensus
2023 A. Gramegna, S. Aliberti, M.A. Calderazzo, R. Casciaro, C. Ceruti, G. Cimino, B. Fabrizzi, C. Lucanto, B. Messore, G. Pisi, G. Taccetti, P. Tarsia, F. Blasi, M. Cipolli
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes
2023 V. Grancini, A. Gramegna, L. Zazzeron, G. Alicandro, L.L. Porcaro, F. Piedepalumbo, C. Lanfranchi, V. Daccò, E. Orsi, F. Blasi
Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups
2023 C. Rosazza, L. Alagna, A. Bandera, A. Biffi, F. Ciciriello, A. Gramegna, V. Lucidi, P.G. Marchisio, P. Medino, A. Muscatiello, S.U. Renteria, C. Colombo
Unplanned pregnancies following the introduction of elexacaftor/tezacaftor/ivacaftor therapy in women with cystic fibrosis
2023 V. Daccò, G. Alicandro, L. Trespidi, A. Gramegna, F.A. Blasi